Related Content
Search Google Scholar for:
|
|
Science 18 January 1980: Vol. 207. no. 4428, pp. 331 - 333 DOI: 10.1126/science.7350667
|
|
Articles
Science, Vol 207, Issue 4428, 331-333
Copyright © 1980 by American Association for the Advancement of Science
Schizophrenia: elevated cerebrospinal fluid norepinephrine
CR Lake,
DE Sternberg,
DP van Kammen,
JC Ballenger,
MG Ziegler,
RM Post,
IJ Kopin,
and
WE Bunney
Concentrations of norepinephrine in cerebrospinal fluid are higher in schizophrenic patients, particularly in those with paranoid features, than in normal volunteer subjects of the same age. This observation supports recent reports of elevated concentrations of norepinephrine in specific brain areas adjacent to the cerebral ventricles of paranoid schizophrenic patients. Overflow of the amine from periventricular regions into the cerebrospinal fluid may reflect abnormally high release or diminished enzymatic destruction of norepinephrine in patients with schizophrenia.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Clinical and Biologic Response to Clozapine in Patients With Schizophrenia: Crossover Comparison With Fluphenazine.
- D. Pickar, R. R. Owen, R. E. Litman, P. E. Konicki, R. Gutierrez, and M. H. Rapaport (1992)
Arch Gen Psychiatry
49, 345-353
| Abstract »
| PDF »
- Cerebrospinal Fluid and Plasma Monoamine Metabolites and Their Relation to Psychosis: Implications for Regional Brain Dysfunction in Schizophrenia.
- D. Pickar, A. Breier, J. K. Hsiao, A. R. Doran, O. M. Wolkowitz, C. N. Pato, P. E. Konicki, and W. Z. Potter (1990)
Arch Gen Psychiatry
47, 641-648
| Abstract »
| PDF »
- Plasma 3-Methoxy-4-Hydroxyphenylglycol Changes Associated With Clinical State and Schizophrenic Subtype.
- G. N. Ko, D. C. Jimerson, R. J. Wyatt, and L. B. Bigelow (1988)
Arch Gen Psychiatry
45, 842-846
| Abstract »
| PDF »
- Noradrenergic Function in Schizophrenia.
- W. M. Glazer, D. S. Charney, and G. R. Heninger (1987)
Arch Gen Psychiatry
44, 898-904
| Abstract »
| PDF »
- Reliability of Norepinephrine and Major Monoamine Metabolite Measurements in CSF of Schizophrenic Patients.
- M. Linnoila, P. T. Ninan, M. Scheinin, R. N. Waters, W.-H. Chang, J. Bartko, and D. P. van Kammen (1983)
Arch Gen Psychiatry
40, 1290-1294
| Abstract »
| PDF »
- {alpha}-Adrenergic Receptor Function in Schizophrenia: Receptor Number, Cyclic Adenosine Monophosphate Production, Adenylate Cyclase Activity, and Effect of Drugs.
- M. S. Kafka and D. P. van Kammen (1983)
Arch Gen Psychiatry
40, 264-270
| Abstract »
| PDF »
- Study of Gluten Effect in Schizophrenia.
- M. M. Singh and S. R. Kay (1983)
Arch Gen Psychiatry
40, 345
| Abstract »
| PDF »
- Plasma Norepinephrine and Dopamine-{beta}-Hydroxylase Activity in Schizophrenia.
- S. Castellani, M. G. Ziegler, D. P. van Kammen, P. E. Alexander, S. G. Siris, and C. R. Lake (1982)
Arch Gen Psychiatry
39, 1145-1149
| Abstract »
| PDF »
- Schizophrenia: dopamine beta-hydroxylase activity and treatment response.
- D. Sternberg, D. VanKammen, P Lerner, and W. Bunney (1982)
Science
216, 1423-1425
| Abstract »
| PDF »
- Long-term Pimozide Pretreatment Differentially Affects Behavioral Responses to Dextroamphetamine in Schizophrenia: Further Exploration of the Dopamine Hypothesis of Schizophrenia.
- D. P. van Kammen, J. P. Docherty, S. R. Marder, J. N. Rayner, and W. E. Bunney Jr (1982)
Arch Gen Psychiatry
39, 275-281
| Abstract »
| PDF »
- Impaired Presynaptic Regulation of Norepinephrine in Schizophrenia: Effects of Clonidine in Schizophrenic Patients and Normal Controls.
- D. E. Sternberg, D. S. Charney, G. R. Heninger, J. F. Leckman, K. M. Hafstad, and D. H. Landis (1982)
Arch Gen Psychiatry
39, 285-289
| Abstract »
| PDF »
- Essential hypertension: central and peripheral norepinephrine.
- C. Lake, H. Gullner, R. Polinsky, M. Ebert, M. Ziegler, and F. Bartter (1981)
Science
211, 955-957
| Abstract »
| PDF »
|
|